Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Rebif (interferon beta-1a subq injection) Treatment Report
What is Rebif?

Rebif, a brand name for interferon beta-1a, is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It is given subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

Side Effects

Side effects as an overall problem

Severe
30 15%
Moderate
77 39%
Mild
69 35%
None
20 10%

Most commonly reported side effects

Injection site redness
117 60%
Muscle ache, whole body
112 57%
Headaches
86 44%
Chills/fever
82 42%
Injection site pain
52 27%
Injection site burning
37 19%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Rebif. See all 81 dosages

  22 mcg/0.5 mL as needed 22mcg/0.5mL as needed 3 times a week 44 mcg/0.5 mL all the time (24/7) 44 mcg/0.5 mL as needed 44mcg/0.5mL as needed 44mcg as needed 44 mg all the time (24/7) 44mg as needed - as needed as needed daily monthly weekly 0.14 mcg 0.44 mg weekly 0.5 mcg weekly 0.44 mcg 0.5 mcg 0.44 mg 0.8 mcg 1 mcg 3 mcg weekly 3 mg weekly 4.4 mcg weekly 30 mcg/0.5 mL monthly 8.8 mcg weekly 3 mcg 4.4 mcg 15 mcg weekly 22 mcg/0.5 mL weekly 22 mcg weekly 22 mg weekly 26.4 mcg weekly 10 mcg 33 mg weekly 12 mcg 40 mcg weekly 44 mcg/0.5 mL weekly 44 mcg weekly 44 mg weekly 8.8 mcg daily 8.8 mg daily 22 mcg 22 mcg/0.5 mL 22 mcg/0.5 mL 3 times a week 3 x 22 mcg/0.5 mL weekly 66 mcg weekly 66 mg weekly 22 mcg 2 x 44 mcg/0.5 mL weekly 88 mcg weekly 33 mcg 99 mcg weekly 112 mcg weekly 40 mcg 120 mg weekly 12 x 44 mcg/0.5 mL monthly 126 mcg weekly 44 mcg 44 mcg/0.5 mL 3 times a week 132 mcg weekly 132 mg weekly 3 x 44 mcg/0.5 mL weekly 152 mg weekly 22 mcg/0.5 mL daily 44 44 mcg 44 mg 4 x 44 mcg/0.5 mL weekly 6 x 44 mcg/0.5 mL weekly 100 mcg 44 mcg/0.5 mL daily 44 mcg/0.5 mL one time 44 mcg daily 132 mcg 138 mcg 132 mcg daily 3 x 44 mcg/0.5 mL daily 321 mcg 44 mcg
  1 Number of Patients: 1 2 Number of Patients: 2 30 Number of Patients: 30 1 Number of Patients: 1 3 Number of Patients: 3 8 Number of Patients: 8 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 12 Number of Patients: 12 1 Number of Patients: 1 23 Number of Patients: 23 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 54 Number of Patients: 54 27 Number of Patients: 27 15 Number of Patients: 15 1 Number of Patients: 1 1 Number of Patients: 1 8 Number of Patients: 8 1 Number of Patients: 1 15 Number of Patients: 15 28 Number of Patients: 28 3 Number of Patients: 3 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 87 Number of Patients: 87 55 Number of Patients: 55 29 Number of Patients: 29 16 Number of Patients: 16 146 Number of Patients: 146 1 Number of Patients: 1 12 Number of Patients: 12 4 Number of Patients: 4 17 Number of Patients: 17 20 Number of Patients: 20 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 75 Number of Patients: 75 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Rebif (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
167 49% Side effects too severe: 49%
Did not seem to work
113 33% Did not seem to work: 33%
Doctor's advice
79 23% Doctor's advice: 23%
Other
57 17% Other: 17%
Personal research
16 5% Personal research: 5%
Expense
14 4% Expense: 4%
Not indicated
9 3% Not indicated: 3%
Course of treatment ended
7 2% Course of treatment ended: 2%

See all 331 patients who’ve stopped taking Rebif

Currently Taking Rebif

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
21
46
80
81
160

Stopped Taking Rebif

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
12
43
52
75
51
95

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
161 82%
Usually
29 15%
Sometimes
3 2%
Never
3 2%

Burden

Difficulty being on treatment

Very
19 10%
Somewhat
58 30%
A little
73 37%
Not at all
46 23%

Cost

Paid out of pocket

$200+
15 8%
$100-199
9 5%
$50-99
35 18%
$25-49
39 20%
< $25
44 22%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.